Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32926933)

  • 1. Berberine inhibits proliferation and induces G0/G1 phase arrest in colorectal cancer cells by downregulating IGF2BP3.
    Zhang Y; Liu X; Yu M; Xu M; Xiao Y; Ma W; Huang L; Li X; Ye X
    Life Sci; 2020 Nov; 260():118413. PubMed ID: 32926933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine promotes IGF2BP3 ubiquitination by TRIM21 to induce G1/S phase arrest in colorectal cancer cells.
    Gui Z; Li J; Li J; Li X; Chen L; Ma Z; Tang X; Gong X; Chai X; Lu F; Li M; Ma H; Li X; Ye X
    Chem Biol Interact; 2023 Apr; 374():110408. PubMed ID: 36822301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
    Xu M; Ren L; Fan J; Huang L; Zhou L; Li X; Ye X
    Life Sci; 2022 Feb; 290():120266. PubMed ID: 34968467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine inhibits the progression of breast cancer by regulating METTL3-mediated m6A modification of FGF7 mRNA.
    Fu W; Liu L; Tong S
    Thorac Cancer; 2024 Jun; 15(17):1357-1368. PubMed ID: 38709912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo.
    Xu W; Sheng Y; Guo Y; Huang Z; Huang Y; Wen D; Liu CY; Cui L; Yang Y; Du P
    J Cell Physiol; 2019 Aug; 234(10):18466-18479. PubMed ID: 30895618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78.
    Gong C; Hu X; Xu Y; Yang J; Zong L; Wang C; Zhu J; Li Z; Lu D
    Anticancer Drugs; 2020 Feb; 31(2):141-149. PubMed ID: 31743135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asiaticoside suppresses cell proliferation by inhibiting the NF‑κB signaling pathway in colorectal cancer.
    Zhou X; Ke C; Lv Y; Ren C; Lin T; Dong F; Mi Y
    Int J Mol Med; 2020 Oct; 46(4):1525-1537. PubMed ID: 32945376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-Cetylberberine inhibits growth of lung cancer in vitro and in vivo.
    Xiao Y; Tian C; Huang T; Han B; Wang M; Ma H; Li Z; Ye X; Li X
    Life Sci; 2018 Jan; 192():259-269. PubMed ID: 29138118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway.
    Kuo HP; Chuang TC; Yeh MH; Hsu SC; Way TD; Chen PY; Wang SS; Chang YH; Kao MC; Liu JY
    J Agric Food Chem; 2011 Aug; 59(15):8216-24. PubMed ID: 21699261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo.
    Zhao Y; Jing Z; Lv J; Zhang Z; Lin J; Cao X; Zhao Z; Liu P; Mao W
    Biomed Pharmacother; 2017 Nov; 95():18-24. PubMed ID: 28826092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Berberine on the Gut Microbiota in Apc
    Wang H; Guan L; Li J; Lai M; Wen X
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
    [No Abstract]   [Full Text] [Related]  

  • 13. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling.
    Ding X; Chen T; Shi Q; Nan P; Wang X; Xie D; Li J
    Exp Cell Res; 2021 Oct; 407(2):112826. PubMed ID: 34508742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
    Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
    J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine inhibits colorectal tumor growth by suppressing SHH secretion.
    Shen ZQ; Wang J; Tan WF; Huang TM
    Acta Pharmacol Sin; 2021 Jul; 42(7):1190-1194. PubMed ID: 32958873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis.
    Noori S; Hassan ZM
    Free Radic Biol Med; 2012 May; 52(9):1987-99. PubMed ID: 22366652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine: Potential preventive and therapeutic strategies for human colorectal cancer.
    Feng Y; Lu J; Jiang J; Wang M; Guo K; Lin S
    Cell Biochem Funct; 2024 Jun; 42(4):e4033. PubMed ID: 38742849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F; Dong X; Lin P; Jiang J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine is a suppressor of Hedgehog signaling cascade in colorectal cancer.
    Sun Q; Tao Q; Ming T; Tang S; Zhao H; Liu M; Yang H; Ren S; Lei J; Liang Y; Peng Y; Wang M; Xu H
    Phytomedicine; 2023 Jun; 114():154792. PubMed ID: 37028248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.